2018 International Congress » Other

Date: Sunday, October 7, 2018

Time: 1:45pm-3:15pm

Location: Hall 3FG

Meeting: 2018 International Congress

1:45pm-3:15pm: 2 cases of Parkinonism secondary to neurosyphilis

M. Li, F. Lou, Y. Ren, X. Luo (Shenyang, China)

1:45pm-3:15pm: A53T mutant human α-synuclein BAC transgenic mice as a model for Parkinson’s disease

T. Taguchi, I. Masashi, M. Uemura, Y. Hatanaka, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)

1:45pm-3:15pm: Accessing Speech and Language Therapy (SLT) in a Multi-Disciplinary Movement Disorders Clinic (MDC)

J. Martin, A. Chatterjee (Reading, United Kingdom)

1:45pm-3:15pm: Acoustic, respiratory, cognitive and wellbeing comparisons of two groups of people with Parkinson’s disease participating in voice and choral singing group therapy (VCST) versus a music appreciation activity

R. Matthews, S. Purdy, L. Tippett (Auckland, New Zealand)

1:45pm-3:15pm: Adolescent onset RBD converting to PD after 48 years

Z. Xu, J. Oliver, K. Anderson (Singapore, Singapore)

1:45pm-3:15pm: An extraordinary cause of psychosis: Anti-NMDA receptor encephalitis

H. Batur Caglayan, F. Sahin, T. Altıparmak, E. Turksoy, S. Candansayar, A. Bora Tokcaer (Ankara, Turkey)

1:45pm-3:15pm: Antiglycine Receptor Antibodies and Rapidly Progressive Corticobasal Syndrome

A. Muñoz González, A. Contreras Chicote, M. Vales Montero, J.M. Velázquez Pérez, B. Dela Casa, E. Luque Buzo, F. Graus, F. Grandas (Madrid, Spain)

1:45pm-3:15pm: Approach to Health Care Shaped by Generational Expectations (The AGE Study): Patients’ preferences for healthcare providers

D. Hengartner, T. Rasameesoraj, J. Lin, O. Hogue, Y. Li, O. Wenzel, E. LaPlante, J. Liang, H. Fernandez, X. Yu (Cleveland, OH, USA)

1:45pm-3:15pm: Approaching Health Care Shaped by Generational Expectations (The AGE Study): A perspective on technology and research

T. Rasameesoraj, D. Hengartner, J. Lin, O. Hogue, E. LaPlante, Y. Li, O. Wenzel, J. Liang, H. Fernandez, X. Yu (Cleveland, OH, USA)

1:45pm-3:15pm: Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time

J. Lin, D. Hengartner, T. Rasameesoraj, O. Hogue, Y. Li, O. Wenzel, E. LaPlante, J. Liang, H. Fernandez, X. Yu (Cleveland, OH, USA)

1:45pm-3:15pm: Are Lewy bodies associated with sympathetic pathology in dementia subjects?

D. Shprecher, M. Callan, B. Cutler, G. Serrano, C. Adler, H. Shill, J. Caviness, M. Sabbagh, C. Belden, E. Driver-Dunckley, S. Mehta, L. Sue, K. Davis, E. Zamrini, T. Beach (Sun City, AZ, USA)

1:45pm-3:15pm: Assessing the potential cost-effectiveness of ads-5102 (Amantadine HCl) for the treatment of dyskinesia in Parkinson’s disease patients

R. Pahwa, L. Garrison, M. Zimmerman, R. Johnson, J. Nguyen, M. Li, R. Patni (Kansas City, KS, USA)

1:45pm-3:15pm: Auditory rhythmic cueing changes motor control during walking in Parkinson’s disease

A. Islam, C. Chen, l. Alcock, K. Nazarpour, L. Rochester, A. Pantall (Newcastle-upon-Tyne, United Kingdom)

1:45pm-3:15pm: Auto-antibodies and clinical-imaging associations in patients with Movements Disorders from a Neurological Institute in Mexico

H. Martinez-Hernandez, N. Gandarilla-Martinez, J. Flores-Rivera, O. Cardenas-Saenz, R. Garcia-Santos, V. Rivas, N. Kerik-Rotenberg, S. Vargas-Cañas, M. Espinola-Nadurille (Mexico City, Mexico)

1:45pm-3:15pm: Baseline predictors of clinical and imaging progression in Parkinson’s disease: Results from the PPMI study

L. Chahine, A. Siderowf, C. Caspell-Garcia, J. Barnes, N. Seedorff, C. Coffey, D. Galasko, B. Mollenhauer, V. Arnedo, N. Daegele, M. Frasier, C. Tanner, K. Kieburtz, K. Marek (Pittsburgh, PA, USA)

1:45pm-3:15pm: Botulinum toxin A (BoNT A) treatment of postsurgical/posttraumatic focal movements not responding to oral therapy

A. Lozza, A. Castagna, G. Castelnovo, E. Alfonsi, A. Montini, L. Marchetta, M. Fresia, A. Arrigo, R. Manni (Pavia, Italy)

1:45pm-3:15pm: C-spine injury with progressive gait difficulty, drop foot, bizarre gait and serum positive stiff person syndrome: A case report

K.W. Chen, K.L. Ho, A.C. Chen, J.J. Lin (Taichung, Taiwan)

1:45pm-3:15pm: Cerebral and pulmonary thromboembolism in a patient with hyperhomocystinemia treated with high dose levodopa/carbidopa intestinal gel

E. Saka Topcuoglu, L. Mehdikhanova, E. Arsava, M. Topcuoglu, B. Elibol (Ankara, Turkey)

1:45pm-3:15pm: Changes in brain network activation (BNA) in patients with fragile x-associated tremor/ataxia syndrome (FXTAS)

T. Fay Karmon, S. Israeli-Korn, G. Yahalom, G. Issachar, Y. Yahav, A. Geva, Z. Peremen, S. Hassin-Baer (Ramat Gan, Israel)

1:45pm-3:15pm: Clinical experiences in Whole systems Ayurveda Management of Parkinson’s Disease

P. Shankar, P. R, P. Devkumar, A. Godbole, U. Muthane (Bangalore, India)

1:45pm-3:15pm: Clinical profiles of late-onset psychiatric patients with incidental REM sleep without atonia

H. Fujishiro, M. Okuda, K. Iwamoto, S. Miyata, Y. Torii, S. Iritani, N. Ozaki (Nagoya, Japan)

1:45pm-3:15pm: Creating a safe home for Parkinson’s disease patients: Designed principles for modifications

T. Jantanapornchai, J. Sringean, S. Pensook, P. Sankham, N. Kantachadvanich, S. Phumphid, R. Bhidayasiri (Bangkok, Thailand)

1:45pm-3:15pm: CRISPR/Cas9-based fluorescent tyrosine hydroxylase-reporter lines

A. Rakovic, F. Vulinovic, C. Klein (Lübeck, Germany)

1:45pm-3:15pm: Diagnostic value and capability of DaT (dopamine-transporter) SEPCT scan to assess clinically uncertain Parkinsonism Diseases as a single institutional experience in Kuwait Population

S. Al Tailji, M. Elgadafi1, W. Kamel, J. Al-Hashel (Kuwait, Kuwait)

1:45pm-3:15pm: Dopaminergic neurons in Substantia Nigra pars compacta code the vigor of movement sequences

M. Mendonça, J. da Silva, L. Hernandez, I. Castela, J. Obeso, R. Costa (Lisboa, Portugal)

1:45pm-3:15pm: Dopaminergic stem cells reside in the rostral migratory stream

K. Schweyer, C. Steiner, G. Höglinger, T. Rösler (Munich, Germany)

1:45pm-3:15pm: Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: A retrospective analysis of medical claims data

J. Ypinga, N. de Vries, L. Boonen, X. Koolman, M. Munneke, A. Zwinderman, B. Bloem (Tilburg, Netherlands)

1:45pm-3:15pm: Effectiveness of peloid therapy in management of Parkinson’s disease (PD): A single center experience

C.S. Khoo, E. Tokareva, O. Rybalko, I. Sukhareva (Cheras, Malaysia)

1:45pm-3:15pm: Effects of Aquatic Physical Therapy on Parkinson’s disease under a vision of the International Classification of Functioning, Disability and Health (ICF)

V. Israel, B. Yamaguchi, M. Ferreira (Curitiba, Brazil)

1:45pm-3:15pm: Evaluation of a driving questionnaire to facilitate awareness of issues that could compromise driving ability in a person with Parkinson’s disease

J. Price, H. Martin, L. Ebenezer (Powys, United Kingdom)

1:45pm-3:15pm: Evidence based management of Normal Pressure Hydrocephalus: Lessons and future directions

A. Mahajan, M. Macki, M. Kaur, M. Novikova, R. Shatz, J. Schwalb (Detroit, MI, USA)

1:45pm-3:15pm: Evolution of Motor and Non-Motor Manifestations in Prodromal Parkinsonism

SM. Fereshtehnejad, C. Yao, A. Pelletier, J. Montplaisir, JF. Gagnon, R. Postuma (Montreal, QC, Canada)

1:45pm-3:15pm: Exploring The Role of a Prescribing Pharmacist in the Management of Parkinson’s Disease

E. Wong (London, United Kingdom)

1:45pm-3:15pm: Eye movement disorders after cerebellar infaction

M. Munteanu (Bucharest, Romania)

1:45pm-3:15pm: Falls in people with Parkinson’s disease: Results from a Multidisciplinary Movement Disorders Clinic in Singapore

D. Tan, S. Balakrishnan, A. Scully, P. Kumar (Singapore, Singapore)

1:45pm-3:15pm: Four eyelid and eye movement disorder cases misdiagnosed as seronegative ocular myasthenia gravis

M. Kamada, K. Kume (Kita-gun, Japan)

1:45pm-3:15pm: Has patients affected by REM sleep Behavior Disorder a specific brain glucose metabolism pattern?

C. Liguori, R. Ruffini, E. Olivola, A. Chiaravalloti, F. Izzi, O. Schillaci, N. Mercuri, F. Placidi (Rome, Italy)

1:45pm-3:15pm: Home Care Programme for Patients with Parkinsonism

WL. Chan, ST. Chua, W. Li, HL. Ng, KY. Tay, WL. Au, CS. Tan (Singapore, Singapore)

1:45pm-3:15pm: Identification of Comprehensive PD Subtypes Using PPMI Study Data with Recurrent Neural Networks

X. Zhang, Y. Zhao, H. Sarva, C. Henchcliffe, F. Wang (New York, NY, USA)

1:45pm-3:15pm: Immediate effects of walking training with Honda Walking Assist Device on gait parameters of Parkinson’s disease

R. Matsugaki, K. Nawata, H. Kako, J. Shiraishi, S. Saeki (Kitakyushu-shi, Japan)

1:45pm-3:15pm: Improving compliance to Parkinsonism’s pharmacotherapy amongst patients attending a Movement Disorders Clinic (MDC)

M. Alsahab, S. Pradhan, A. Chatterjee (Reading, United Kingdom)

1:45pm-3:15pm: Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series

C. Wang, E. Wang, H. Lei (Tucson, AZ, USA)

1:45pm-3:15pm: Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy?

A. Mook, S. Gunzler, G. Wilmot, A. Shaikh (Cleveland, OH, USA)

1:45pm-3:15pm: Is there a role for miRNA in the diagnosis of PD?

A. Garvey, N. Cutfield, J. Williams (Dunedin, New Zealand)

1:45pm-3:15pm: Life Expectancy for Parkinson Patients at Hoehn and Yahr Stage 5

W. Li, H.L. Ng, S. Acharyya, K.Y. Tay, W.L. Au, L. Tan (Singapore, Singapore)

1:45pm-3:15pm: Longitudinal alpha-synuclein in cerebrospinal fluid in early Parkinson’s disease, prodromal PD and healthy controls

B. Mollenhauer, C. Caspell-Garcia, C. Coffey, P. Taylor, A. Singleton, L. Shaw, J. Trojanowski, M. Frasier, T. Simuni, A. Siderowf, K. Marek, D. Galasko (Kassel, Germany)

1:45pm-3:15pm: Metabolomic Profiling of Activated Microglial Cells

V. Vedam-Mai, T. Domenick, E. Gill, T. Garrett, R. Yost, M. Okun (Gainesville, FL, USA)

1:45pm-3:15pm: Models of Parkinson’s disease in vitro

A. Dilzoda (Tashkent, Uzbekistan)

1:45pm-3:15pm: Motor and Non-motor Features Predict Freezing of Gait in Parkinson’s Disease

N. D'Cruz, G. Vervoort, S. Fieuws, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)

1:45pm-3:15pm: Parkinson’s disease-related non-motor features as risk factors for post-operative delirium in spinal surgery

SY. Kang, KH. Kim, DA. Shim, SW. Choi, MJ. Son, YH. Sohn, PH. Lee (Hwaseong, Republic of Korea)

1:45pm-3:15pm: Parkinson’s disease, peripheral neuropathy, impaired gait, and the role of physiotherapy

M. Alvarez (San Antonio, TX, USA)

1:45pm-3:15pm: Parkinsonism with rare sequence variants in VPS35 and FBXO7 genes associated with Lewy body pathology

K. Mensikova, L. Tuckova, R. Vodicka, K. Kolarikova, T. Bartonikova, J. Ehrmann, R. Vrtel, P. Kanovsky (Olomouc, Czech Republic)

1:45pm-3:15pm: People with PD have significantly impaired lower limb force production in all muscle groups: A cross sectional study

E. Preston, R. Salmon, N. Mahendran, A. Flynn (Canberra, Australia)

1:45pm-3:15pm: Pre-supplementary Motor Area Contributes to Motor Aspects of Sequential Risk-Taking

A. Lohse, D. Meder, A. Løkkegaard, H. Siebner (Hvidovre, Denmark)

1:45pm-3:15pm: Predicting Alpha-Synuclein Pathology by REM Sleep Behavior Disorder Diagnosis

D. Shprecher, C. Adler, N. Zhang, J. Hentz, G. Serrano, B. Dugger, H. Shill, R. Savica, J. Caviness, M. Sabbagh, C. Belden, E. Driver-Dunckley, S. Mehta, L. Sue, K. Davis, E. Zamrini, T. Beach (Sun City, AZ, USA)

1:45pm-3:15pm: Progressive encephalomyelitis with rigidity and myoclonus (PERM): Phenomenology, investigations and management of two recent cases

T. Munteanu, Y. LLamas-Osorio, P. Cullinane, T. Lynch (Dublin, Ireland)

1:45pm-3:15pm: Pronounced synucleinopathy and nigrostriatal degeneration result in forelimb use deficits in the rat preformed alpha-synuclein fibril model

J. Patterson, M. Duffy, T. Collier, K. Luk, C. Kemp, J. Howe, P. Patel, A. Stoll, K. Miller, N. Kanaan, K. Paumier, C. Sortwell (Grand Rapids, MI, USA)

1:45pm-3:15pm: Recruitment of Minority populations with Parkinson’s disease at an Urban Hospital

C. Branson, S. Bissonette, T. Johnson, J. Weinberg, M. Saint-Hilaire (Boston, MA, USA)

1:45pm-3:15pm: Relationship of 10-Meter Walk Test to balance performance in Parkinson’s disease patients as a predictor of falls

A.P.C. Loureiro, B. Yamaguchi, V. Israel (Curitiba, Brazil)

1:45pm-3:15pm: REM sleep-related episodes in children with Narcolepsy type 1 after treatment with Sodium Oxybate

E. Antelmi, F. Pizza, G. Plazzi (Bologna, Italy)

1:45pm-3:15pm: Rotenone model of Parkinson’s disease: The dosing options in mice revisited

M. Raza, N. Zehra, S. Malhi (Karachi, Pakistan)

1:45pm-3:15pm: Severe Gliosis following PPN-DBS

V. Vedam-Mai, A. Elkouzi, B. Malhotra, S. Raman, A. Yachnis, K. Foote, M. Okun (Gainesville, FL, USA)

1:45pm-3:15pm: Sniffing Parkinson’s in the masses: Volatilome analysis for Parkinson’s Disease diagnostics

M. Silverdale, D. Trivedi, E. Sinclair, Y. Xu, C. Liscio, P. Banks, T. Kunath, R. Goodacre, P. Barran (Manchester, United Kingdom)

1:45pm-3:15pm: Spectrum of movement disorders in patients of autoimmune encephalitis of non-neoplastic aetiology

D. Dash, M. Tripathi, K. Ihtisham (Delhi, India)

1:45pm-3:15pm: Spectrum of movement disorders with anti-neuronal antibodies: Case series

A. Kumar, S. Mehta, V. Lal (Chandigarh, India)

1:45pm-3:15pm: Speech and Language Therapy (SLT) for Inpatients with Parkinson’s (IwP) in a Large District General Hospital

J. Martin, A. Chatterjee (Reading, United Kingdom)

1:45pm-3:15pm: STN-DBS responsive motor complication and pathological gambling in type IV SCA3

M. Kuo, C. Tai, R. Wu (New Taipei, Taiwan)

1:45pm-3:15pm: Submandibular gland is a suitable tissue for alpha synuclein pathology in Parkinson’s disease

JH. Shin, SH. Park, CW. Shin, JH. Kim, TJ. Yun, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

1:45pm-3:15pm: Surface Modified Solid Lipid Nanoparticles for the targeted delivery to brain: Management of HIV-1 Associated Dementia

S. Bhargava, V. Bhargava (Kanpur, India)

1:45pm-3:15pm: Task effects on lingual kinematics in dysarthric individuals with Parkinson’s disease: Insights from two cases

M. Wong (Hong Kong, Hong Kong)

1:45pm-3:15pm: The epiphenomenon of movement disorders post-stroke period

J. Shodmonov, B. Muinjanov (Tashkent, Uzbekistan)

1:45pm-3:15pm: The Impact of short in-patient rehabilitation courses for people with Parkinson´s disease

S. Kinos, K. Martikainen, T. Vahlberg, R. Marttila (Turku, Finland)

1:45pm-3:15pm: The scaling properties of chorea and levodopa-induced dyskinesia are similar to voluntary movements

J. Daneault, C. Duval, J. Miranda (Newark, NJ, USA)

1:45pm-3:15pm: The severity of motor symptoms and depression are the higher predictor for the decrease in daily living activities independence in people with Parkinson’s disease

C. Dionizio Dias, E. Okamoto, C. Miranda, M. d'Alencar, M.E. Piemonte (São Paulo, Brazil)

1:45pm-3:15pm: The use of a clinical “exercise -immobility test” in a patient with paroxysmal hypnogenic dyskinesia

A. Shalash, A. Abushouk, H. Elrasas (Cairo, Egypt)

1:45pm-3:15pm: Using APPs in a Movement Disorders clinic can quickly and efficiently increase the number of new patients seen without compromising patient satisfaction

J. Atem, L. Lanford (Dallas, TX, USA)

1:45pm-3:15pm: Visual impairment and falls in Parkinson’s disease (PD)

N. Butt, M. Khwaja, A. Chatterjee (Reading, United Kingdom)

1:45pm-3:15pm: What increases the risk of malnutrition in geriatric Parkinson’s disease population?

M. Gultekin, F. Fırat Ozer, S. Akın, A. Ozturk (Kayseri, Turkey)

1:45pm-3:15pm: Which is the best manual test to predict the daily living activities’ independence in people with Parkinson’s disease?

C. Dionizio Dias, E. Okamoto, C. Miranda, M. d'Alencar, M.E. Piemonte (São Paulo, Brazil)

« View all sessions from the 2018 International Congress.